TCTMD Your source for breaking news, topical videos, and slides covering cardiovascular disease and interv

TCTMD is the most comprehensive on-line resource in interventional cardiology and provides indepth coverage of the percutaneous treatment of cardiovascular disease. Since its launch at TCT 2000, TCTMD has provided clinicians and industry professionals myriad ways to keep up-to-date in the ever-evolving field, including news and data from conferences hosted around the world as well as information about the latest devices and drugs used in the daily practice of cardiovascular medicine.

06/13/2025

Only a minority consistently meet timely targets set out by the AHA and ACC. This is a “call to action,” Harold Dauerman says.

06/13/2025

Using the PREVENT risk equation, one-fifth were at high risk over 10 years, rising to two-thirds over the next 30 years.

06/13/2025

Alcohol is a hot topic—the new statement sums up the evidence and provides ways to help patients understand the risks.

06/12/2025

Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.

06/12/2025

Suzanne Baron and David Elison discuss when to intervene in cases of asymptomatic aortic stenosis based on the complete patient profile.

06/11/2025

The imaging was better than societal recommendations at discriminating long-term risk of ventricular arrhythmias.

06/11/2025

Roxana Mehran speaks with Scott Solomon about where the field's at and what the future holds.

Dimitrios Karmpaliotis, an interventional cardiologist known both as a master operator and beloved mentor, died suddenly...
06/10/2025

Dimitrios Karmpaliotis, an interventional cardiologist known both as a master operator and beloved mentor, died suddenly this week. “We will dearly miss his indomitable spirit, mentoring, and special friendship,” Martin Leon says, joining colleagues in mourning.

Karmpaliotis leaves behind a legacy of teaching his profound skills in complex PCI and his passion for patients and family.

06/10/2025

Lp(a) only modestly improved prediction when added to risk estimates, but it still can be used to personalize care.

06/10/2025

The GLUCOSE model recommends insulin doses that are tailored to each patient’s blood-sugar fluctuations.

06/10/2025

With the factor XI inhibitor, clinicians may have more flexibility when managing anticoagulation in this common scenario.

06/10/2025

The combination will be available in several doses and is also approved as a first-line option for patients with hypertension.

Address

1700 Broadway
New York, NY
10019

Alerts

Be the first to know and let us send you an email when TCTMD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Our Story

TCTMD is the most comprehensive on-line resource in interventional cardiology and provides indepth coverage of the percutaneous treatment of cardiovascular disease. Since its launch at TCT 2000, TCTMD has provided clinicians and industry professionals myriad ways to keep up-to-date in the ever-evolving field, including news and data from conferences hosted around the world as well as information about the latest devices and drugs used in the daily practice of cardiovascular medicine.